SCHEDULE: Patient Capital Management Discloses 24.6% Stake in Precigen

Patient Capital Management, LLC and Patient Opportunity Trust have reported a combined beneficial ownership of 24.6% of Precigen, Inc.'s common stock.

Summary

• Patient Capital Management, LLC and Patient Opportunity Trust collectively hold 24.6% of Precigen, Inc.'s common stock.
• Patient Capital Management, LLC beneficially owns 45,223,463 shares, representing 13.6% of the class.
• Patient Opportunity Trust, a Series of Advisor Managed Portfolios, beneficially owns 35,786,370 shares, representing 11% of the class.
• Both reporting persons exercise sole voting and dispositive power over their respective shares.

Sentiment

Score: 6

Explanation: The filing discloses a substantial combined beneficial ownership of 24.6% in Precigen, Inc. by Patient Capital Management, LLC and Patient Opportunity Trust. While a Schedule 13G is a factual ownership report, a significant institutional stake can be interpreted as a positive signal of investor confidence in the company's long-term prospects.

Positives

• Significant institutional ownership by Patient Capital Management, LLC and Patient Opportunity Trust, totaling 24.6% of Precigen's common stock, indicates a strong conviction in the company.

Future Outlook

NA

Industry Context

This filing represents a standard disclosure of significant beneficial ownership by institutional investors in a publicly traded company, common across various industries as part of regulatory compliance.

Stakeholder Impact

• Shareholders: The significant stake held by Patient Capital Management and Patient Opportunity Trust may provide a level of stability and confidence, potentially influencing other investors' perceptions of Precigen's value.

Key Dates

Keywords

Precigen, Patient Capital Management, Patient Opportunity Trust, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Equity Stake